Asset Detail: FDA Approves XDEMVY™ (lotilaner ophthalmic solution) 0.25% for the ...

Academic Figure
Download Source File
1920px (Presentation) 1280px (Standard) 800px (Web)

Asset Information

Source Context: This media is attached to the document XDEMVY DRUSDD.M!XG SIDE EFFECTS .

Usage: Authorized for internal review, study guides, and academic presentations. Please cite the original document when embedding this asset.

← Return to Source Document